Idiopathic Pulmonary Fibrosis (IPF) Research Solutions

Date Published:

Watch our video to learn how our digital solutions and clinical science expertise can support the development of better IPF treatments and therapeutic options by helping to:

  • Mitigate variability and inconsistencies from clinician-reported outcome assessments
  • Simplify the electronic completion of patient-reported outcome assessments
  • Reduce participation and travel burdens by facilitating virtual study visits
  • Streamline the consent and reconsent processes